Moreover, Ligers et al. have genotyped for CTLA-4 polymorphisms and have explored the expression by PBMC of CTLA-4 mRNA and protein when comparing MS patients, myasthenia gravis patients, and healthy controls [118]. The gene discussed is CTLA4; the disease is myeloid sarcoma.